CDT Equity CDT
NASDAQ CDT
$1.36 -0.09 (-6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

CDT Equity (CDT) Other Non-Current Liabilities (2023 - 2026)

Updated

CDT Equity's Other Non-Current Liabilities came in at $264,000 for Q2 2026, compared with $1,000 a year earlier.

Analysis

CDT Equity (CDT) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends

At the end of FY2024, CDT Equity's Other Non-Current Liabilities was $138,000, down 97.6% from FY2023.

  • Going back by year, Other Non-Current Liabilities was $5.74 million in FY2023.
  • The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CDT Equity 34,330.48 34,330.48 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 264,000.00
Sep 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 8.00 Mn
Dec 31, 2024 138,000.00
Sep 30, 2024 24,000.00
Jun 30, 2024 32,000.00
Mar 31, 2024 100,000.00
Dec 31, 2023 5.74 Mn
API Access

CDT Equity Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CDT&period=max&api_key=YOUR_API_KEY